Hubbell HUBB Price Action Q4 2025 Earnings Underperform Is HUTCHMED HCM stock strengthening its trend HUTCHMED China Limited ADS notches 150 pct EPS beat vs loss estimates CLRB Cellectar Biosciences Inc reports narrower than expected Q4 2025 loss yet shares drop nearly 3 percent JACS Jackson quarterly earnings show all metrics undisclosed investors await management commentary on outlook CVNA Q1 2026 Earnings EPS Beats Estimates by Over 12 Stock Surges 6 MTDR Q1 2026 Earnings Strong EPS Beat Boosts Investor Sentiment Beyond Air Inc XAIR Q1 2026 Earnings Narrowed Loss Slightly Exceeds Expectations as Clinical Pipeline Advances HNRG Q1 2026 Earnings WiderThanExpected Loss Amid Challenging Coal Market TransCode Therapeutics Q4 2024 Earnings WiderthanExpected Loss Reflects ClinicalStage Investment TUSK Q1 2026 Earnings Return to Profitability Drives Shares Higher